The largest database of trusted experimental protocols

6 protocols using akt 11e7

1

Endothelial Cell Signaling Pathway

Check if the same lab product or an alternative is used in the 5 most similar protocols
All chemicals and reagents were purchased from Sigma-Aldrich (St. Louis, MO) unless otherwise specified. Antibodies against Tie2 (C-20) (Santa Cruz Biotechnology, Inc.), Tie2 (clone Ab33) (Merck Millipore), GATA3 (D13C9) (Cell Signaling), MMP14/MT1-MMP (D1E4) (Cell Signaling), pAKT (Ser473, D9E) (Cell Signaling), AKT (11E7) (Cell Signaling) and ubiquitin (Cell Signaling) β-tubulin and GAPDH (Santa Cruz Biotechnology, Inc.) were used. Soluble Tie2 levels were determined using the human Tie-2 DuoSet ELISA and the mouse Tie-2 Quantikine Kit. HUVECs were stimulated with TNFα, Angpt-1 and Angpt-2 (all from R&D systems, Minneapolis, MN).
+ Open protocol
+ Expand
2

Protein Expression Analysis Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
GAPDH (6c5), E-cadherin (H-108), Vimentin (V9) and MMP-2 (H-76) antibodies were purchased from Santa Cruz Biotechnology (PasoRobles, CA). Phospho-Akt (Ser473 D9E) and Akt (11E7) antibodies were purchased from Cell Signaling Technology Company (Boston, MA), Phospho-mTOR (ab109268) and mTOR (ab32028) antibodies were from Abcam Company (San Diego, CA). CD68 (M087601-2) antibody were purchased from DAKO (Carpinteria, CA). Rapamycin was from Cell Signaling Technology Company (Boston, MA). Crystal violet was from Fishers Scientific Company (Grand Island, NY). Anti mouse/rabbit second antibody for Western Blot and Lipofectamine 2000 transfection reagent were purchased from Life Technologies Company (Grand Island, NY).
+ Open protocol
+ Expand
3

Investigating Angpt-2 and Tie2 Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
All chemicals and reagents were purchased from Sigma-Aldrich (St. Louis, MO) unless otherwise specified. Antibodies against Angpt-2 (AF623) (R&D Systems, Minneapolis, MN), mAngpt-2 (Clone #748246) (R&D Systems, Minneapolis, MN), Tie2 (C-20) (sc-324, Santa Cruz Biotechnology, CA), pTie2 (Y1102/Y1100) (R&D systems, Minneapolis, MN), Gr-1 (AbD Serotec), Lcyopersicon esculentum agglutinin (LEA, tomato lectin) (Vector Laboratories, Burlingame, CA), Akt (11E7) (Cell Signaling Technology, Cambridge, UK), pAkt (Ser 473) (Cell Signaling Technology, Cambridge, UK), pJNK (G-7) (sc-6254, Santa Cruz Biotechnology, CA), JNK (Cell Signaling Technology, Cambridge, UK) and GAPDH (FL-335) (Santa Cruz Biotechnology, CA) were utilized. As secondary antibodies we used goat anti-rabbit IgG-HRP (Santa Cruz Biotechnology, CA) and donkey anti-goat IgG-HRP (Santa Cruz Biotechnology, CA). The FDA approved drug library was obtained from Enzo Life Sciences (Farmingdale, NY).
+ Open protocol
+ Expand
4

Immunoblotting Protocol for Myeloid and T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Twenty-five milligrams CD11b+ bone-marrow-derived myeloid cell or splenic T cell lysates were prepared as described for immunoprecipitation were electrophoresed on 10% SDS-PAGE gels and immunoblotted to detect MLCK210 (MYLK N-17, #sc-22223 or H195 Santa Cruz Biotechnology, #sc25428 each at 1:1000 dilution), integrin α4 (EPR1355Y, Abcam #ab81280 at 1:1000 dilution), HSP90 (Santa Cruz sc101494 at 1:1000 dilution), pSer18/pThr19 myosin light chain (Cell Signaling 3674 at 1:1000 dilution), myosin light chain 2 (Cell Signaling 3672 at 1:1000 dilution), pAkt (244F9, Cell Signaling at 1:1000 dilution), Akt (11E7, Cell Signaling at 1:1000 dilution), Flag tag (F7425, Sigma at 1:1000 dilution), myosin heavy chains A (Cell Signaling 3403 at 1:1000 dilution), myosin heavy chain B (Cell Signaling 3404 at 1:1000 dilution), myosin heavy chains C (Cell Signaling 3405 at 1:1000 dilution), paxillin (Santa Cruz 5574 at 1:1000 dilution), or Talin (Santa Cruz H-300 at 1:1000 dilution). All antibodies were diluted in TBST+ 5% BSA. Images of uncropped blots with molecular weight markers are included in the Source Data, available at 10.6084/m9.figshare.19358147.v1 and in the Source Data file that accompanies this article.
+ Open protocol
+ Expand
5

DNMT3A Knockout Effects on Cell Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
DNMT3A KO and WT HEK293 cells of 1 ×10 6 were washed with PBS, lysed using 100 μL RAPA lysis buffer containing protease inhibitors cocktail (Roche; Penzberg, Germany), and separated by a 10% SDS-PAGE. After transferring onto a 0.45 μm PVDF membranes, immunoblotting was performed. For detection of DNMT3A deficiency, primary mouse monoclonal antibody against GAPDH (Sangon; Shanghai, China) and polyclonal rabbit-anti-human DNMT3A (Sangon) were used at 1:1000 dilution. For detection of MAPK and PI3K-Akt pathways, primary monoclonal antibodies against human Erk (137F5; Cell Signaling Technology; Danvers, MA, USA), phosphor-Erk (197G2; Cell Signaling Technology), JNK (D-2; Santa Cruz; Dallas, TX, USA), phosphor-JNK (G9; Cell Signaling Technology), Akt (11E7; Cell Signaling Technology), and phosphor-Akt (244F9; Cell Signaling Technology) were used. HRP-conjugated anti-mouse IgG or anti-rabbit IgG antibodies (Jackson ImmunoResearch; PA, USA) were used for secondary antibodies. Signals were detected with enhanced chemiluminescence (Millipore; MA, USA) and visualized with a gel imaging system (Tanon; Shanghai, China).
+ Open protocol
+ Expand
6

Uterine Histopathology and Immunohistochemistry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
A midsection (between the fimbrial end and cervical end) from a fixed uterine horn was embedded in paraffin and sectioned at 5 mm. Sections were either stained with hematoxylin and eosin (H&E) for histopathological analyses or used for immunohistochemistry. Immunostaining was performed as previously described in Gao et al. (2014) (link). The antibodies used were ERa (sc-542, Santa Cruz Biotechnology, 1:200 dilution), progesterone receptor (PR; sc-538, Santa Cruz Biotechnology, 1:100), PTEN (138G6, Cell Signaling, 1:50), AKT (11E7, Cell Signaling, 1:50), P-AKT (D9E, Cell Signaling, Danvers, MA, USA, 1:50), and p27 (sc-528, Santa Cruz Biotechnology, 1:50). The immunopositivity and immunointensity of ERa were assessed by the H score as previously described (McNamara et al. 2013) (link). Different compartments of uterus were assessed separately: glandular epithelial cells, luminal epithelial cells, stroma, and myometrium. In brief, the H score was obtained by assessing immunointensity (scales of 0-3) and prevalence in 100 cells over five different areas in stroma and myometrium and prevalence in 20 cells over five different areas in glandular and luminal epithelial cells. All slides were counted twice to assess inter-observer variability.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!